The intersection of technology and mental health has spurred innovative approaches to assessing emotional well-being, particularly through computational techniques applied to audio data analysis. This study explores the application of Convolutional Neural Network (CNN) and Long Short-Term Memory (LSTM) models on wavelet extracted features and Mel-frequency Cepstral Coefficients (MFCCs) for emotion detection from spoken speech. Data augmentation techniques, feature extraction, normalization, and model training were conducted to evaluate the models' performance in classifying emotional states. Results indicate that the CNN model achieved a higher accuracy of 61% compared to the LSTM model's accuracy of 56%. Both models demonstrated better performance in predicting specific emotions such as surprise and anger, leveraging distinct audio features like pitch and speed variations. Recommendations include further exploration of advanced data augmentation techniques, combined feature extraction methods, and the integration of linguistic analysis with speech characteristics for improved accuracy in mental health diagnostics. Collaboration for standardized dataset collection and sharing is recommended to foster advancements in affective computing and mental health care interventions. NTRODUCTION In recent years, the intersection of technology and mental health has opened up new avenues for assessing and understanding emotional well-being, with a particular focus on leveraging computational techniques for analyzing spoken speech.

The launch of ChatGPT has garnered global attention, marking a significant milestone in the field of Generative Artificial Intelligence. While Generative AI has been in effect for the past decade, the introduction of ChatGPT has ignited a new wave of research and innovation in the AI domain. This surge in interest has led to the development and release of numerous cutting-edge tools, such as Bard, Stable Diffusion, DALL-E, Make-A-Video, Runway ML, and Jukebox, among others. These tools exhibit remarkable capabilities, encompassing tasks ranging from text generation and music composition, image creation, video production, code generation, and even scientific work. They are built upon various state-of-the-art models, including Stable Diffusion, transformer models like GPT-3 (recent GPT-4), variational autoencoders, and generative adversarial networks. This advancement in Generative AI presents a wealth of exciting opportunities and, simultaneously, unprecedented challenges. Throughout this paper, we have explored these state-of-the-art models, the diverse array of tasks they can accomplish, the challenges they pose, and the promising future of Generative Artificial Intelligence.

Deep Neural Networks (DNNs) have performed admirably in classification tasks. However, the characterization of their classification uncertainties, required for certain applications, has been lacking. In this work, we investigate the issue by assessing DNNs' ability to estimate conditional probabilities and propose a framework for systematic uncertainty characterization. Denoting the input sample as x and the category as y, the classification task of assigning a category y to a given input x can be reduced to the task of estimating the conditional probabilities p(y|x), as approximated by the DNN at its last layer using the softmax function. Since softmax yields a vector whose elements all fall in the interval (0, 1) and sum to 1, it suggests a probabilistic interpretation to the DNN's outcome. Using synthetic and real-world datasets, we look into the impact of various factors, e.g., probability density f(x) and inter-categorical sparsity, on the precision of DNNs' estimations of p(y|x), and find that the likelihood probability density and the inter-categorical sparsity have greater impacts than the prior probability to DNNs' classification uncertainty.

Adverse drug events (ADEs) are a serious health problem that can be life-threatening. While a lot of studies have been performed on detect correlation between a drug and an AE, limited studies have been conducted on personalized ADE risk prediction. Among treatment alternatives, avoiding the drug that has high likelihood of causing severe AE can help physicians to provide safer treatment to patients. Existing work on personalized ADE risk prediction uses the information obtained in the current medical visit. However, on the other hand, medical history reveals each patient's unique characteristics and comprehensive medical information. The goal of this study is to assess personalized ADE risks that a target drug may induce on a target patient, based on patient medical history recorded in claims codes, which provide information about diagnosis, drugs taken, related medical supplies besides billing information. We developed a HTNNR model (Hierarchical Time-aware Neural Network for ADE Risk) that capture characteristics of claim codes and their relationship. The empirical evaluation show that the proposed HTNNR model substantially outperforms the comparison methods, especially for rare drugs.

Clustering is concerned with coherently grouping observations without any explicit concept of true groupings. Spectral graph clustering - clustering the vertices of a graph based on their spectral embedding - is commonly approached via K-means (or, more generally, Gaussian mixture model) clustering composed with either Laplacian or Adjacency spectral embedding (LSE or ASE). Recent theoretical results provide new understanding of the problem and solutions, and lead us to a 'Two Truths' LSE vs. ASE spectral graph clustering phenomenon convincingly illustrated here via a diffusion MRI connectome data set: the different embedding methods yield different clustering results, with LSE capturing left hemisphere/right hemisphere affinity structure and ASE capturing gray matter/white matter core-periphery structure.